NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹316 Cr | ₹374 Cr | ₹362 Cr | ₹234 Cr | ₹218 Cr |
What is the latest Sundry Debtors ratio of NEULAND LABORATORIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹316 Cr |
| Mar2024 | ₹374 Cr |
| Mar2023 | ₹362 Cr |
| Mar2022 | ₹234 Cr |
| Mar2021 | ₹218 Cr |
How is Sundry Debtors of NEULAND LABORATORIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹316 Cr | -15.48 | |
| Mar2024 | ₹374 Cr | 3.25 | |
| Mar2023 | ₹362 Cr | 54.39 | |
| Mar2022 | ₹234 Cr | 7.62 | |
| Mar2021 | ₹218 Cr | - | |
Compare Sundry Debtors of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹17,511.7 Cr | -1.8% | -5.9% | -11.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | -0.5% | 1.8% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,192.0 Cr | -0.3% | -1.3% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 4.4% | 6% | 27.7% | Stock Analytics | |
| CIPLA | ₹108,513.0 Cr | 1% | -3% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.1% | 8% | 3.8% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -1.8% |
-5.9% |
-11.1% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses